Fosamax News - Jaw & Femur Injuries
Fosamax News
  • FDA Presents Data for Long-Term Fosamax Use

    ADELPHI, MD

    In the early morning session of today's FDA Panel conference on the long term use of bisphosphonates, like the drug Fosamax, the FDA's Lead Medical Officer Fatmatta Kuyateh, M.D. indicated that radiographic findings consistent with atypical femur fractures case have been associated with bisphosphonate use.

    read more

Pages